U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H19NO2
Molecular Weight 209.2848
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Crisugabalin

SMILES

[H][C@@]12C[C@H]3C[C@]1([H])[C@](CN)(CC(O)=O)[C@]2([H])CC3

InChI

InChIKey=WCEFMBSFXJUREW-LIJGXYGRSA-N
InChI=1S/C12H19NO2/c13-6-12(5-11(14)15)9-2-1-7-3-8(9)10(12)4-7/h7-10H,1-6,13H2,(H,14,15)/t7-,8-,9+,10-,12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C12H19NO2
Molecular Weight 209.2848
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:51:37 UTC 2023
Edited
by admin
on Sat Dec 16 19:51:37 UTC 2023
Record UNII
Q3MK7E8686
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Crisugabalin
INN  
Official Name English
crisugabalin [INN]
Common Name English
Tricyclo[4.2.1.03,8]nonane-2-acetic acid, 2-(aminomethyl)-, (1S,2S,3R,6S,8S)-
Systematic Name English
HSK-16149
Code English
(1S,2S,3R,6S,8S)-2-(Aminomethyl)tricyclo[4.2.1.03,8]nonane-2-acetic acid
Systematic Name English
HSK16149
Common Name English
Code System Code Type Description
FDA UNII
Q3MK7E8686
Created by admin on Sat Dec 16 19:51:37 UTC 2023 , Edited by admin on Sat Dec 16 19:51:37 UTC 2023
PRIMARY
INN
12414
Created by admin on Sat Dec 16 19:51:37 UTC 2023 , Edited by admin on Sat Dec 16 19:51:37 UTC 2023
PRIMARY
CAS
2209104-84-5
Created by admin on Sat Dec 16 19:51:37 UTC 2023 , Edited by admin on Sat Dec 16 19:51:37 UTC 2023
PRIMARY
NCI_THESAURUS
C199029
Created by admin on Sat Dec 16 19:51:37 UTC 2023 , Edited by admin on Sat Dec 16 19:51:37 UTC 2023
PRIMARY
PUBCHEM
139300919
Created by admin on Sat Dec 16 19:51:37 UTC 2023 , Edited by admin on Sat Dec 16 19:51:37 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
PreventS [3H]gabapentin from binding in a dose-dependent manner. Lowers calcium influxupon activation.
IC50
Related Record Type Details
ACTIVE MOIETY